Brief: GH Research PLC Posts Qtrly Net Loss Of $10.9 Mln
May 11 (Reuters) - GH Research PLC GHRS.O :
* GH RESEARCH PLC - EXISTING CASH, CASH EQUIVALENTS, OTHER
ASSETS,
MARKETABLE SECURITIES TO BE SUFFICIENT TO FUND OPERATING
EXPENSES, CAPEX INTO 2026
* GH RESEARCH PLC - QTRLY NET LOSS WAS $10.9 MILLION, OR
$0.210
LOSS PER SHARE
Source text for Eikon: ID:nGNX837Szq
Further company coverage: GHRS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on GH Research
See all newsCorrected: UPDATE 2-Experts urge FDA to set clear safety and access standards for psychedelic drugs (September 14)
FDA to hold public hearing on psychedelic drugs as Trump-driven push gathers pace
Ireland's GH Research Q2 net loss widens on higher R&D costs
AtaiBeckley surges after report Lilly poised to buy psychedelic drug developer
Street View: Psychedelic sector gains after report Lilly nears AtaiBeckley acquisition